Tag: post-approval drug monitoring
The FDA monitors generic drug safety after approval through real-time reporting, manufacturing data, and patient feedback. Learn how adverse events are tracked, what gaps exist, and what’s changing in 2025 to improve detection of quality and effectiveness issues.
Medications
Archives
Recent-posts
Preparing for Doctor Appointments: What to Bring and Discuss
Jan, 26 2026
Environmental Risk Factors for Rhabdomyosarcoma: What You Need to Know
Sep, 28 2025
Generic vs Brand-Name Drugs: Key Differences Explained
Jan, 30 2026
How to Talk to Your Doctor About New Drug Safety Alerts
Jan, 8 2026
Biltricide (Praziquantel) vs Alternative Anthelmintics: A Practical Comparison
Sep, 25 2025